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Abstract:  
Prunella vulgaris (PV) is a perennial herb belonging to the Labiate family and is widely 
distributed in northeastern Asian countries such as Korea, Japan, and China. It is reported to 
display diverse biological activities including anti-microbial, anti-cancer, and anti-
inflammation as determined by in vitro or in vivo studies. So far, about 200 compounds have 
been isolated from PV plant and majority of these have been characterized mainly as 
triterpenoids, sterols and flavonoids, followed by coumarins, phenylpropanoids, 
polysaccharides and volatile oils. This review summarizes and analyzes the current knowledge 
on the chemical constituents, pharmacological activities, mechanisms of action and clinical 
applications of the PV plant including its potential as a future medicinal plant. Although some 
of the chemical constituents of the PV plant and their mechanism of action have been 
investigated the biological activities of many of these remain unknown and further clinical 
trials are required to further enhance its reputation as a medicinal plant.   
Keywords: Prunella vulgaris, constituent, activity, application, review 
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1. Introduction 
In recent years, interest in the development of herbs and botanicals from plants for use as 
drugs has significantly increased [1]. Natural products such as microbial metabolites are a rich 
source for the development of new drugs as they display diverse chemical structures and 
biological activities [2]. Prunella vulgaris (PV), also known as self-heal, is a plant belonging 
to the Labiatae family and is traditionally used as folk medicine in Northeastern Asian countries 
such as Korea, Japan, and China [3]. The Chinese name for this plant is Xia-Ku-Cao which 
originates from a description that the herb is dried and withered after the summer solstice [4]. 
It is reported to be rich in bioactive chemicals, including polysaccharides, flavonoids, 
triterpenes and phenolic acids. Thus, PV has many notable pharmacological activities, such as 
anti-colitic, antioxidant, anti-inflammatory, anticancer, neuroprotective [5], antiestrogenic [6], 
and anti-metastatic effects [7]. In China, it is also extensively used as a health-promoting food 
or tea. For example, PV is a principle raw material of Guangdong Herbal Tea well known as 
Wanglaoji-Liang-Cha, which has been historically consumed as a healthy beverage in Southern 
China [8]. In Europe, this plant is also consumed widely as food or tea on a regular basis [9]. 
Although dietary supplement manufacturers cannot legally make disease claims without 
approval of a new drug application, the unsubstantiated medical uses for many botanical dietary 
supplements are well known and promoted in literature and news media or on the Internet 
although dietary supplement manufacturers cannot legally make such claims [10].  
Plants have always been a very good source for research and development of new drugs 
and many beneficial uses of medicinal plants are extensively documented as traditional 
medicines in many cultures. The present review mainly focuses on the in vitro an in vivo studies 
involving PV. The compounds and extracts which display potential pharmacological properties 
are presented in Tables 1 and 2, respectively. Some of the major effective phytochemicals 
present in PV are listed in Table 3. It has also been reported that out of  the 21 herbs screened 
for either estrogenic or antiestrogenic activitiy using the alkaline phosphatase assay only PV 
extract displayed the strongest biological activity [11]. Meanwhile, SKI 306X, a purified 
extract from a mixture of three oriental herbal medicines (Clematis mandshurica, 
Trichosanthes kirilowii and Prunella vulgaris), has been widely used for the treatment of 
inflammatory diseases such as lymphadenitis and arthritis in Far East Asia [12]. The current 
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state of research regarding the medicinal use of PV is summarised in this review. 
2. Phytochemistry 
Natural products are compounds or substances produced by living organisms (or found in 
nature), which have pharmacological or biological activities often used for drug discovery and 
design [13]. These plant metabolites have noteworthy structural complexity and a variety of 
pharmacological and biological activities, making them effective nutritional compounds and 
pharmaceutical drugs. Many bioactive constituents from PV have been identified, including 
phenolic constituents, complex carbohydrates and hydrophobic metabolites such as triterpenes. 
The aqueous extract contains abundant polyphenols, rosmarinic acid and complex 
carbohydrates, whereas more hydrophobic metabolites, such as triterpenes and flavonoids 
along with some polysaccharides and polyphenols, are found in the ethanol extract [14, 15]. 
The abundant polysaccharides have a number of reported biological activities, such as 
antioxidant and immunomodulatory [9]whilst several of the triterpenes display significant anti-
inflammatory activity. Rosmarinic acid has also shown to be an anti-inflammatory compound 
due to its specific inhibition of T cell signaling and its impact on glucose metabolism [15].  
2.1 Triterpenoids and saponins 
The triterpenoids isolated from PV are mainly oleanane, lupinane and ursane. At present, 
a total of 28 triterpenoids have been isolated: 20 triterpenoids (free state), 8 saponins (binding 
state); the two compounds with highest content, oleanolic acid (1) and ursolic acid (2), are 
mainly resoponsible for the pharmacological acticity of PV.  
Many compounds have also been isolated from methylated PV extracts such as methyl 
oleanolate (3), methyl ursolate (4), methyl maslinate (5) and other related compounds [16-18]. 
Pravuloside A (6) and Pravuloside B (7) along with two ursane-type specific triterpenoid 
saponins have also been isolated from PV [19, 20]. Some other compounds present in PV,  are 
vulgarsaponin A (8) [21] and vulgarsaponin B (9) [22], which is a newly identified  
glucopyranoside compound (Fig.1).  
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(1) Oleanolic acid                     (2) Ursolic acid                      (8) Vulgarsaponin A                           (9 ) Vulgarsaponin B 
 
Structure Groups R1 R2 R3 R4 R5 R6 
 
(3)  Methyl oleanolate H β-OH CH3 CH3 H CH3 
(4)  Methyl ursolate H β-OH CH3 CH3 CH3 H 
(5)  Methyl maslinate OH β-OH CH3 CH3 H CH3 
 
 
 
(6)  Pruvuloside A 
(7)  Pruvuloside B 
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Fig 1. Structures of triterpenes 
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2.2 sterols 
The main sterols present in in PV include: β-sitosterol (10), stigmasterol (11), α-spinolol (12), and stigmast-7-en-3β-ol (13) [23]. Eight sterol 
compounds have been isolated from the ear, stem, leaf and other parts of PV, of which four compounds are present in a free state: ducosterol (14), 
α-spinasterol, β-sitosterol, stigmasterol-7-olefinic alcohol; The other four compounds are glucose glucosides: stigmast-7-enyl-β-D-gluco-
pyranoside (13), (22E,20S,24S)-stigmast-7,22-diene-3-ene (15), α-spinasterolyl-β-D-glucopyranose glucoside, stigmasterolyl-β-D-glucopyranose 
glucoside [24] (Fig. 2). 
 
 
 
Sketon 1                  Sketon 2 
 
R2a                  R2b 
 R1 Sketon+R2 
(10) Sitosterol α-OH 1a 
(11) Stigmasterol α-OH 1b 
(12) Spinasterol α-OH 2b 
(13) Stigmast-7-en-3β-ol β-OH 2a 
(14) Ducosterol =O  
(15) (22E，20S，24S)-stigmast-7,22-diene-3-ene β-OH 2a 
Fig 2. Structures of steroids and derivatives 
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2.3 Flavonoids 
In addition to rutin (16) and hyperoside, three other flavonoids have been isolated and 
identified from PV, namely luteolin (17), homoorinetin (18) and cinaroside (19) [24]. Besides 
these compounds, PV also contains quercetin (20), quercetin-3-O-β-D -galactoside (21) [25], 
quercetin-3-O-β-D-glucoside (22), kaempferol-3-O-β-D-glucoside (23) [26] and other related 
components (Fig. 3). 
 
(16) Rutin 
 
 
 
 
 
 
 R1 R2 R3 
(17)Luteolin H H OH 
(18)Homoorinetin H Glc OH 
(19)Cinaroside H O-
Glc 
OH 
(20)Quercetin H H OH 
(21)Quercetin-3-
O-β-D-galactoside 
Glc H OH 
(22)Quercetin-3-
O-β-D-glucoside 
Glc H OH 
(23)Kaempferol-3-
O-β-D-glucoside 
Glc H H 
Fig. 3 Structure of steroids 
 
2.4 Coumarins 
Pv is reported to contain only small amounts of coumarin although Dmitruk [27] is 
reported to have isolated three coumarin compounds. The calculation of managerial constants 
and infrared spectroscopy identified these asc umbelliferone (24), scopoletin (25) and esculetin 
(26) (Fig.4). 
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(24)Umbelliferon H 
(25)Scopoletin OMe 
(26)Esculetin OH 
Fig. 4 Structure of Coumarins 
 
2.4.1 Phenylpropanoids  
Phenylpropanoids present in PV include: P-cumaric acid (27), cis-caffeic acid and trans-
caffeic acid (28), rosmarinic acid (29), and others such as methyl rosmarine, ethyl rosmarine, 
E-butyl rosmarine, 3,4α-trihydroxy-methyl-phenyl propionate, 3,4α- trihydroxy-butyl-phenyl 
propionate [28] (Fig. 5).  
 
   
(27)P-cumaric acid          (28) caffeic acid                 (29) rosmarinic acid 
 
Fig. 5 Structure of Phenylpropanoids 
 
2.6 Long-chain fatty acids 
PV contains long-chain fatty acids such as palmitic acid, ethyl palmitate, tetracosanoic 
acid, stearic acid, 6,9-octodecadienoic acid, 3,6,7-eicosatrienoic acid, oleic acid, peanut oleic 
acid,  moringoic acid, lauric acid, myristic acid, linolenic acid, palmitic acid, myristic acid, 
and linoleic acid [25-29]. 
2.7 Volatile oils 
The volatile components present in PV include 1,8-eucalyptol,  β-pinene, myrcene, 
linalylacetate, α-phellandene, linalool, 1,6-cyclononone, palmitic acid and trihexadecane. 
Among these, the content of 1,8-anthracene and β-pinene is the highest, and accounts for more 
than 60% of the total volatile oils [30]. 
2.8 Sugar 
PV contains free monosaccharides (mainly rhamnose, glucose, xylose, arabinose, 
mannose, galactose, etc [31], disaccharides (sucrose and fructose) and polysaccharides. In 
addition, a sulfur-containing polysaccharide has also been isolated from PV [32].  
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2.9 Other components 
Alkaloids, inorganic salts, vitamins, resins, bitter taste, tannic acid, proteins and lipids are 
also present in PV. 
3. Pharmacology 
3.1 Antitumor activity 
   Anti-tumor activities of extracts and monomeric compounds from PV plant have been 
investigated [33]. PV inhibits metastasis and promotes the apoptosis of many different kinds 
of tumor cells through different pathways. Triterpene compounds 2α-hydroxy ursolic acid and 
ursolic acid significantly inhibit breast cancer cells MCF-7, MDA-MB-231 and normal breast 
cells MCF-10A. Betulinic acid is reported to inhibit only breast cancer cells MCF-7 and MDA-
MB-231, but has no effects on normal breast cells MCF-10A [34].  
In addition, some studies have demonstrated that 19α-hydroxy ursolic acid and quercetin 
present in PV ethanol extract can inhibit the migration of tumor cells MDA-MB-231 in a dose-
dependent manner, in which quercetin reduces the proliferation of tumor cells by inhibiting the 
PI3k/Akt pathway. IC50 of 19α-hydroxy ursolic acid and quercetin against MDA-MB-231 cells 
migration was 1.676 μmol • L-1 and 1.145 μmol • L-1, respectively [35]. The effect of prunella 
polysaccharide-zinc complex (P1-Zn) on HepG2 liver cancer cells has been confirmed by 
morphological changes, chromatin agglutination and G0/G1 cell cycle arrest. P1-Zn complex 
increases the expression of caspase-3 and -9, excessive production of reactive oxygen species 
and destruction of mitochondrial function to achieve effective inhibition of HepG2 cell 
proliferation [36]. PV also alleviated thyroid cancer symptoms through increase of Bcl-2-
related protein X and caspase-3 levels by inducing apoptosis of thyroid cancer TPC-1 and FTC-
133 cell lines and down-regulating B-cell lymphoma-2 expression in TC-1 and FTC-133 
expression [37]. Recent studies [38, 39] have also demonstrated that PV has significant 
inhibitory effects on lymphoma cell Jurkat, human lung cancer cell A-549, endometrial cancer 
cell Ishikawa, and cholangiocarcinoma cells QBC939 and RBE. 
3.2 Anti-inflammation and immunoregulation 
Inflammation is a potential risk factor in the development of many diseases and can create 
or exacerbate a range of diseases. Traditional Chinese medicines play a two-way immune 
regulatory role in the body, and the mechanisms of action is mainly related to immune organs, 
immune cells, immune molecules promotion, inflammatory response, hypersensitivity [40]. 
Many active components of PV such as rosmarinic acid and ursolic acid have significant 
anti-inflammatory and immunosuppressive effects. The water extracts of PV stems and leaves 
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markedly inhibited carrageenan induced rat paw swelling and xylene-induced mouse auricular 
swelling, reduced the content of tumor necrosis factor-α [41]. 
3.3 Antiviral effect 
     According to the lesions, the number of herpes zoster, the typical lesion score, and the 
expression levels of HSV-1 and HSV-2 in the lesion tissue, the guinea pig model of HSV-1 
(skin) was established with HSV- Virus DNA copy number as an indicator. Prunella 
polysaccharide was found to not only inhibit the activity of the HSV-1 and HSV-2 in vitro, but 
also decrease HSV-1 and HSV-2 virus lesions in the guinea pig model, showing the better anti-
herpes simplex virus activity [42]. 
3.4 Anti-oxidative effect 
PV displays significant antioxidant activity [43]. High performance liquid 
chromatography (HPLC) and LC/MS analyses has shown that the main active compounds from 
60% ethanol extract of PV (P-60) are phenols, such as caffeic acid, rosmarinic acid, rutin and 
quercetin. Total phenols are highly correlated with the antioxidant activity, and significantly 
inhibit tumor growth in C57BL/6 mice, increase superoxide dismutase (SOD) activity and 
decrease malondialdehyde (MDA) content in serum of tumor-bearing mice [44].  
In addition, triterpenes, flavonoids and polysaccharides have the strongest antioxidant 
activity. The total reactive oxygen species (ROS), hydrogen peroxide (H2O2), and 
malondialdehyde (MDA) were measured in the shackle Balb/C mice model, and the activities 
of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) were also analyzed, 2.50 
g∙kg-1 of PV reduced the levels of H2O2, ROS, protein peroxide protein carbonyl; 1.25, 2.50, 
7.50 g∙kg-1 of PV decreased the content of lipid peroxidation MDA and increased the activity 
of SOD. Besides, the water extract of PV can reduce the pyrazole-lipopolysaccharide-induced 
oxidative stress in mice liver tissue by inhibiting the protein expression of CYP2E1 and 
CYP2A5 [45]. 
3.5 Anti-osteoporosis 
   The flavonoid extract of PV shows anti-osteoporosis effect through promoting osteoblast 
function in ovariectomized rats, reducing bone resorption and bone metabolism, increasing 
bone formation and decreasing trabecular bone loss and bone mass loss.[46]. 
3.6 Anti-depression 
   The antidepressant effect of PV was investigated by use of mouse tail suspension, forced 
swimming and spontaneous activity tests with fluoxetine hydrochloride as a positive control 
drug. The water extract could increase the levels of 5-hydroxytryptamine, norepinephrine and 
dopamine in hippocampus of hippocampus, and decrease the content of cyclooxygenase -2, 
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prostaglandin E, interleukin-1β, interleukin-6, indicating that the anti-deprssion effect of PV 
aqueous extract may be achieved by increasing the content of monoamine neurotransmitter in 
hippocampal tissue and reducing the content of inflammatory cytokines Antidepressant effect 
[47]. 
3.7 Hypoglycemic, hypotensive and hypolipemic effects 
Hyperglycemia and glycosylated hemoglobin (HbA1c) are widely used as diagnostic 
markers for diabetes [48]. The proper management of diabetes includes blood glucose and 
HbA1c homeostasis, and improvement of antioxidant defenses by minimizing free radical 
adverse effects [49]. The indigenous hemoprotein antioxidant enzyme, catalase (CAT), directly 
scavenges the reactive oxygen species (ROS) and catalyzes the lessening and detoxification of 
hydrogen peroxides [50-52]. By using an alloxan-induced type 1 diabetes (T1D) mouse model, 
bio-guided fractionation, isolation, RP-HPLC, and 1H and 13C NMR identification, the active 
components of PV were determined: rosmarinic acid (RA), caffeic acid (CA, most active 
fraction ) and p-coumaric acid(pCA), hence named, caffeic acid-rich fraction (CARF). CARF 
reduced blood glucose levels and improved in-vivo oxidative-stress. It also inhibited the 
carbohydrate-hydrolyzing enzymes (alpha-amylase and alpha-glucosidase) and reduced 
HbA1c levels more significantly than PV extract, CA or RA. In the longer time, CARF 
significantly increased serum-insulin, ameliorated thermal hyperalgesia and tactile allodynia 
more significantly than PV extract, CA or RA. Moreover, the tested compounds showed 
potential restoration of the lipid peroxide levels. CARF and PV extract were observed to 
increase serum-insulin and attenuate alpha-amylase and alpha-glucosidase, whose antioxidant 
potentials might be responsible for their antidiabetogenic and antinociceptive properties [53]. 
The stems, leaves, spikes, and the whole grass of PV have antihypertensive effect. The 
main active component is the total saponin. The water, 30% alcohol and ethanol - water extracts 
of PV exert antihypertensive effect on anesthetized animals. The water extract can reduce blood 
pressure by reducing the systolic pressure and diastolic pressure of SHR rats, significantly 
inhibit the alpha-amylase, alpha-glucosidase, and reduce the postprandial blood glucose levels 
of normal mice and alloxan diabetic mice, improve starch tolerance, promote liver glycogen 
synthesis and lower blood sugar. PV can also inhibit atherosclerosis, hyperlipidemia to some 
extent [54]. 
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Table 1. The compounds with pharmacological activities from PV 
Compound Model Observation Dosage Activity Mechanism of action Refs. 
2,3-dihydroxyurs-12-en-28-oic 
acid (DHURS) 
human acute leukemia 
Jurkat T cells 
in vitro 20–25 
μg/ml 
Induces 
apoptosis 
Mitochondria-dependent activation of caspase cascades [55] 
Ursolic acid and betulinic acid MCF7 human breast cancer 
cell line and LNCaP (CRL-
1740) human prostate cancer 
cell line 
in vitro 20,50 μM Anti-estrogenic Inhibited estrogen signaling by suppressing the expression of 
estrogen receptor α (ERα) and enhanced prostate-specific antigen 
promoter activity 
[56] 
Rosmarinic acid (RA) UVA-induced changes in 
a human keratinocyte cell 
line (HaCaT) 
in vitro 25–50 
mg/l 
Photoprotection Suppressed UVA-induced ROS production ， reduced DNA 
damage，and inhibited UVA-induced caspase-3 activation 
[57] 
 
Table 2. The extracts with pharmacological effects from PV 
Extract Model /Cell type Observation Dosage Activity Mechanism of action Refs. 
Aqueous extract Carbon tetrachloride-induced 
hepatic fibrosis 
In vivo 50, 100, and 200 
mg/kg 
Anti-fibrosis Inhibited the activation of hepatic stellate cells, promoted 
collagenolysis and regulated fibrosis-related microRNAs 
[3] 
60% Ethanol extract Tumor-bearing C57BL/6 
Mice 
In vitro, and in 
vivo  
5 and 10 g crude 
drug/kg  
Antioxidant Antioxidant and inhibition of the tumor growth [58] 
Methanol extract   Mouse Xenograft In vitro, and in 
vivo 
50 μg/ml Antiestrogen Inhibited estrogen responses [6] 
Ethylacetate extract Doxorubicin-induced 
oxidative stress 
In vitro 0.005 to 0.05 mg/ml Cardioprotect Antioxidant capacity [59] 
Water extraction 
followed by alcohol 
precipitation 
Female BALB/c mice in vivo 0.90 g/kg Anti-inflammation 
and anti-tumor 
Enhanced the activity of T lymphocytes in general and its 
subgroup Th cells and No significant changes in B 
lymphocytes 
[60] 
Ethanol extract LPS-activated RAW 264.7 In vitro and in 10, 50 and 100 Treatment of sepsis Induced heme oxygenase-1 (HO-1) expression through [61] 
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Cells and and CLP-induced 
Septic Mice 
vivo μg/ml PI3K/Nrf2 signal pathways and a reduction of high 
mobility group box 1(HMGB1) 
Aqueous extract Human T cell lymphotropic 
virus type 1-immortalized T 
cell lines MT-2 and MT-4 cells 
In vitro 10, 50 μM Anti-HIV activity Inhibited syncytium formation and resultant cell death [62] 
Aqueous extract murine macrophage RAW 
264.7 cells 
In vitro 10, 50, 100 μg/ml Immunostimulatory 
and anti-tumor 
activity 
Stimulated macrophage activation via NF-κB 
transactivation and MAP kinase activation 
[63] 
70% Ethanol extract The mouse macrophage cell 
line RAW264.7, human liver 
cancer cell line HepG2, 
human colon cancer cell line 
HT29, human lung cancer cell 
line A549, human stomach 
cancer cell line MKN-45 and 
human cervical cancer cell 
line HeLa 
In vitro 10, 50, 100 μg/ml Anti-oxidant and 
anti-cancer 
Increased the expression of p53, Bax and Fas [64] 
Aqueous extract HeLa37 cells In vitro 0.1, 1, 10 μg/ml Anti-viral Inhibited HIV-1 infectivity [14] 
Aqueous extract male Sprague-Dawley rats 
and  
rat peritoneal mast 
cells (RPMC) 
In vivo 0.005 to 1 g/kg Inhibition of  
immediate-type 
allergic reactions 
Inhibited the passive cutaneous anaphylaxis activated by 
anti-dinitrophenyl (DNP) IgE antibody dose dependently 
and suppressed the histamine release induced by 
compound 48/80 or anti-DNP IgE 
[65] 
Aqueous extract murine peritoneal 
macrophages 
In vitro 50, 100, 200, 400 
μg/ml 
Immunomodulatory 
and 
antiinflammatory 
activities 
Stimulated the proliferation of T-lymphocytes and 
suppressed NO production in lipopolysaccharide-
stimulated macrophages 
[66] 
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Aqueous extract Equine dermis cells In vitro 66 μg/mL or 62.4 
μg/mL 
Inhibition of equine 
infectious anemia 
virus (EIAV) 
replication 
Prevented viral particles from binding to the surface of 
permissive cells       
[15] 
Ethanolic extract mdr1a-/- or wild type FVBWT 
mice 
In vivo 2.4 mg/d Anti-inflammation Maintained mucosal homeostasis in mdr1a/ mice by 
regulating gene expression associated with innate 
inflammatory responses and attenuating the activation of 
the adaptive immune response 
[67] 
Aqueous extract INS-1 cells In vitro 100 µg/ml Anti-inflammation Signifcantly prevented IL-1β-increased INS-1 cell death 
and LDH activity and attenuated IL-1β-increased 
caspase-3 activity 
[68] 
Aqueous ethanol 
extract (30% v/v) 
lipopolysaccharide (LPS) -
induced 
oxidative damage and 
inflammation in human 
gingival fibroblasts 
In vitro 5, 10, 25µg/ml Anti-inflammation Reduced reactive oxygen species (ROS) production, 
intracellular glutathione (GSH) depletion as well as lipid 
peroxidation, inhibited LPS-induced up-regulation of 
interleukin 1b (IL-1b), interleukin 6 (IL-6), tumor 
necrosis factor-a (TNF-a), and suppressed expression of 
inducible nitric oxide synthase (iNOS) 
[69] 
80% Ethanol extract alloxan-induced diabetic mice In vivo 50, 100 and 150 
µg/ml 
Hypoglycemic and 
antinociceptive 
effects 
Increased serum-insulin and attenuated alpha-amylase 
and alpha-glucosidase 
[70] 
50% Ethanol extract UVB-aged normal human 
dermal fibroblasts 
In vitro 10, 100 μg/mL Protection of 
normal human 
dermal fibroblasts 
(NHDFs) from 
UVB‐induced 
inflammatory and 
Inhibited MAPKs, AP-1, and NF-κB signaling and 
promoted the TGF‐β1/Smad pathway 
[71] 
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photo aging damage 
Aqueous extract Human umbilical vein 
endothelial cells (HUVEC) 
In vitro stock solution 
corresponding to 5 g 
raw PVL per ml 
Upregulation of 
endothelial NO 
synthase (eNOS)  
Increased Enos promoter activity, eNOS mRNA and 
protein expressions, as well as NO production. 
[72] 
Ethyl acetate parts of 
aqueous extract 
scopolamine (SCOP)-induced 
aging rats 
In vitro and in 
vivo 
100 mg/kg Anti-dementia Attenuated SCOP-induced brain senescence in rats by 
improving behavioral performance and decreasing brain 
cell damage, reduced AChE activity and MDA level, 
increased SOD and GPx activities, and inhibited the 
expression of NF-κB and GFAP. 
[73] 
Aqueous extract human umbilical vein 
endothelial cells 
In vitro 10, 30, 50 μg/mL Anti-inflammation Inhibited ROS/NF-κB pathway by inducing HO-1 and 
eNOS expression mediated by Nrf2 
[74] 
Ethanol extract RAW 264.7 Mouse 
Macrophages 
In vitro 30 μg/mL Anti-inflammation inhibited lipopolysaccharide (LPS)-stimulated 
prostaglandin E2 (PGE2) and nitric oxide (NO) 
production. 
[75] 
Ethanolic extract normal naive mice In vivo 25 or 50 mg/kg Enhances cognitive 
performance 
Increased neural cell proliferation and the number of 
immature neurons, enhanced ERK, Akt and GSK-3β 
phosphorylation levels and up-regulated adult 
hippocampal neurogenesis. 
[76] 
Aqueous extract Human fibrosarcoma HT-
1080, mouse melanoma B16-
F1 and B16-F10 cells 
In vitro and In 
vivo 
10,50,100,200 
μg/ml 
Anti-invasion and 
anti-metastasis 
Suppression of MMP-9 expression by the inhibition of 
NF-κB via ERK1/2 signaling pathway as well as MMP-
9 activity 
[7] 
Ethanolic extract Male ICR mice In vivo 25 
or 50 mg/kg 
Anti-amnesia Ameliorated scopolamine-induced cognitive 
impairments. 
[77] 
Aqueous extract Human liver carcinoma 
HepG2, Huh-7 and Hep3B 
cells 
In vitro 1, 5 and 10 mg/ml Anti-invasion and 
anti-metastasis 
Inhibited activities of metalloproteases, MMP-2 and 
MMP-9, without affecting cell viabilities, and suppressed 
migration through attenuation of enzymatic activities of 
[78] 
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MMP-9 and MMP-2 at transcriptional levels 
 
Table 3. The phytochemicals categories with pharmacological properties from PV 
Effective 
phytochemicals 
Model /Cell type dosage Observation Activity Mechanism of action Refs. 
Polysaccharides Murine macrophage RAW 264.7 
cells 
125, 250, 
500, 1000 
μg/mL 
In vitro Antioxidation and 
immunomodulation 
Stimulated the production of pro-inflammatory 
cytokines, including nitric oxide (NO), tumor 
necrosis factor- (TNF-), and interleukin-6 (IL-6) 
[9] 
Lignin–polysaccharide 
complex 
BALB/c mice 10,20,30,40,
50 μg/mL 
In vivo Anti-herpes Inhibited viral binding and penetration into host cells [79] 
Polysaccharide HSV-1 and HSV-2 100 μg/mL In vitro Anti-HSV Inhibited HSV by competing for cell receptors [80] 
Phenolics-rich Hereditary 
hypertriglyceridemic rats or 
high-sucrose diet (HSD, 70 
cal% of sucrose) for two 
weeks 
1% w/w In vivo Antioxidation Suppressed a high-sucrose diet induced oxidative 
stress and positively modified lipoprotein 
cholesterol profile in plasma of hereditary 
hypertriglyceridemic insulin-resistant rats 
[81] 
Polysaccharide-zinc HepG2 cells 500 μg/mL In vitro Antiproliferation Activated caspase-3 and -9, reactive oxygen species 
(ROS) overproduction and mitochondrial 
dysfunction 
[82] 
Polysaccharide Human breast carcinoma-
associated fibroblasts 
5 μg/mL, 8 
μg/mL 
In vitro Anti-migration and anti- 
apoptosis 
Inhibited basic fibroblast growth factor (bFGF) 
expression, and suppressed the growth of breast 
cancer SKBr-3 cells. 
[83] 
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4. Clinical efficacy of Prunella vulgaris preparation 
In recent years, a variety of (PV) preparations have been widely used in clinical practice. 
Many of diseases treated by PV alone or in combination with other medicinal plants have given 
receive satisfactory results. Although most traditional Chinese medicines have only moderate 
therapeutic effects on diseases, they have few side effects compared with Western medicines. 
Furthermore, a large number of Chinese medicines can alleviate or eliminate the adverse 
reactions caused by western medicine and help the body to recover, reducing the recurrence 
rate. Currently PV is clinically applied for production of various preparations, such as 
injections, oral liquid, and ointment. Although PV is the main herb medicine, the efficacy of 
preparations varies with the addition of excipients, the extraction methods of medicinal 
substances, and the administration routes in the preparation process. 
4.1 Granules 
Rosmarinic acid, a major pharmacological agent of PV [84], has a number of activities, 
such as anti-inflammation, elimination of swelling, immune regulation and anti-thyroid, and is 
obtained from the water extract of PV and excipients processing, which is prepared as granular. 
Clinical research [85] founded that 356 cases of menopausal women were randomly divided 
into both the control group (181 cases) and the observation group (175 cases), and the control 
group were given cyclosporine eye drops and the observation group additional Prunella 
granules. After treatment, the amount of tear fluid and the time of tear film rupture in the 
observation group were significantly higher than those in the control group. The corneal 
topographic map corneal surface regular index, corneal surface irregular index, conjunctival 
epithelial cells TNF-α, IL-1β, ICAM -1 significantly reduced, indicating that PV granules has 
a significant efficacy in the treatment of menopausal women with dry eye.  
When hyperthyroidism is treated with Western drug methimazole tablets, the long period 
of treatment is necessary due to the slow improvement of thyroid function. However, long-term 
use of methimazole tablets alone will inevitably lead to many side effects. Therefore the 
treatment with Western medicine alone is not considered ideal. Given the treatment with PV 
granules combined with methimazole tablets, the granules can enhance the function of 
methimazole and relieve its side responses owing to the efficacy of PV with clearing away heat 
and toxic material. A clinical study [86] showed that in the combination therapy group, the 
efficiency (91.84%) was significantly higher than that of methimazole alone (75.51%), and the 
difference was statistically significant (P <0.05). 
4.2 Tablets 
PV extract is dried and pressed into tablets. The preparation has anti-tumor, antibacterial, 
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anti-inflammatory, liver protective effects, etc. In one study for observing the clinical efficacy 
of PV tablets on benign prostatic hyperplasia [87], the control group was given finasteride and 
the observation group given additional PV tablets. Prostate volume and prostate specific 
antigen in the observation group were improved compared to the control group, and the adverse 
reaction rate (5.0%) in the observation group was significantly lower than that in the control 
group (32.5%), these differences were statistically significant (P<0.05). A recent study [88] 
disclosed that PV tablets had better clinical effects, fewer adverse reactions, and shorter course 
of treatment in the treatment of acute thyroiditis when combined with glucocorticoid. In 
another clinical study on acute mastitis, PV tablets combined with antibacterial penicillin could 
evidently improve the symptoms, restore the normal breastfeeding and reduce the patient's 
resistance to antibacterials. PV tablets combined with adapalene gel also showed a significant 
clinical effect in the treatment of acne vulgaris [89].  
4.3 Ointment 
PV ointment is composed of PV, licorice, Scrophulariaceae and 14 other herbs. These 
herbs are decocted with water, concentrated into a clear paste, and appropriate amount of 
refined honey or sucrose is added and heated which turns this into a concentrated into dark 
brown semi-fluid formulations. PV ointment also has the efficacy of clearing fire, loosing knot 
and eliminating swelling. For 50 cases with thyroid nodules [90], the total effective rate was 
76.00% when treated with PV ointment combined with thyroxine tablets, while the total 
effective rate was only 42.00% in the patients treated with thyroid hormone tablets alone. The 
difference was statistically significant (P <0.05). Therefore the combination therapy has more 
obvious treatment effect, and can be widely used in clinic. 
4.4 Oral solution 
  The preparation of PV oral solution is obtained by decoction with water, filtration, and 
concentration, followed by addition of sodium benzoate and sucrose which is then dissolved 
by heating the mixture. PV oral solution possesses several effects, such as anti-bacteria, anti-
inflammation, dissipating binds and dispersing swelling, clearing heat and purging fire. The 
effect of PV oral liquid combined with betamethasone in the treatment of patients with subacute 
thyroiditis was more significant than that of betamethasone alone. The total effective rate 
(81.40%) was significantly higher in the combination group than in the betamethasone alone 
group (81.40%) [91]. A clinical study [92] showed that the total effective rate was 75.68% and 
the recurrence rate in one year was 36.84% when the chronic breast cancer patients were treated 
with the combination of PV with oral antibiotics (cefdinir dispersible tablets). The rates were 
significantly lower than those of patients treated with antibiotics alone. 
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4.5 Capsules   
PV capsules are made by concentration of PV water extract plus brown sugar filled in 
empty capsules or soft capsules. The preparation possesses anti-tumor, immune regulative and 
anti-inflammatory analgesic effects. In a clinical study on Hashimoto's thyroiditis, PV capsules 
combined with levothyroxine sodium tablets apparently enhanced thyroid hormone levels in 
patients when compared with patients given L-thyroxine alone. The levels of thyroid 
peroxidase antibody and thyroglobulin antibody were significantly lower in the combination 
administration group than in the group given levothyroxine alone. This indicates that PV 
capsules have a significant effect on improving Hashimoto's thyroid function, lowering thyroid 
antibody levels, etc. [93]. 
5. Conclusions and prospects 
In summary, PV is a widely distributed plant and is a very popular and commonly used 
traditional medicine for the treatment of clinical disorders. It is a widely investigated plant 
worldwide due to its promising therapeutic properties. In China, this plant has been used 
historically as a health food and traditional Chinese medicine (TCM) for the treatment of 
jaundice, hepatitis, gonorrhea, tuberculosis and diabetes mellitus [94]. In vivo and in vitro 
studies have provided the evidence of its various ethnomedical and potential pharmacological 
activities, indicating its effectiveness against many diseases. PV plant has rich chemical 
composition, and the major chemical components include triterpenoids and their glycosides, 
flavonoids, phenolic acids and their glycosides, organic acids, sterols, essential oils and 
saccharides. Of these, tannins and polysaccharides exhibit very good antiviral activities. The 
triterpenoids show anti-tumor activity, and the fractions enriched in phenolic acids, phenol 
components and polysaccharides have antioxidation activity whilst both rosmarinic acids and 
its derivatives possess anti-inflammatory activity. Polysaccharides, the main compounds 
isolated from Prunella vulgaris, are considered as biological response modifiers (BRMs) for 
their antioxidant, anticancer, and immune-modulating activities. These biological activities are 
affected by their unique structural characteristics of polysaccharides. The antioxidant activities 
are related to their compositions of proteins and uronic acid and structural features of molecular 
weights, monosaccharide composition and types of glycosidic. 
In recent years, some investigations on biological activities of PV have been carried out 
on animal and at cell levels. PV single formulations and compound prescriptions have been 
been used in clinical practice with encouraging results. PV prapartions can be used alone in 
clinic or be combined with western medicines for the treatment of thyroiditis, breast 
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hyperplasia, cancer and other diseases. Owing to the efficacy for clearing away liver-fire, 
dissipating binding depression and so on, the "edible" PV gradually integrates with the 
"Chinese medicine" boom, and a series of PV life products are available for health protection, 
such as herbal tea (withered tea), ingredients (cold Prunella, Prunella porridge), and daily 
necessities (dried tangerine peel). 
However, further research is needed to clarify the targets of the active compounds from 
PV, understand the mechanisms involved, and characterize the metabolites responsible for 
these activities. In addition, these promising compounds or their class should be extracted and 
purified by using more advanced technologies to treat increasing health issues including cancer, 
diabetes, tuberculosis and other diseases. Furthermore, the relationship between the biological 
properties and traditional uses should be clearly verified through valid studies. In conclusion, 
PV is a medicinal resource with great potential for development and should be further studied 
in all aspects, so as to extract, purify and synthesize active compounds under the premise of 
quality standard determination, and provide series of daily necessities ingredients and 
medicinal substances with highly effective and low toxic properties. 
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